Research On Cost Control Of TH Pharmaceutical Company

In recent years,with the deepening of the national medical reform work,especially during the 13th Five-Year Plan period,many industrial policies and regulations have been issued,such as process verification,two-vote system,drug clinical data verification,medical insurance control fee,graded diagnosis and treatment,public hospital reform,and so on.These policies and regulations have also been introduced one after another,which will have a significant impact on the investment activities,financing activities,business models,product development and sales of pharmaceutical manufacturing enterprises.At the same time,there are many problems in pharmaceutical manufacturing industry,such as high financing cost,low profit and difficulty in R&D.If a pharmaceutical manufacturing enterprise can't adapt to the rapid change of industry policy by scientific and reasonable methods,and fails to take active and effective actions to improve and innovate its own system,then its daily activities may be adversely affected and the risks may be great.A big increase.Therefore,strengthening cost control has become a problem that pharmaceutical manufacturing enterprises must pay attention toThis paper chooses the traditional Chinese patent medicine manufacturing industry as the case study object,TH Pharmaceutical Company,a large Chinese patent medicine pharmaceutical enterprise.Firstly,it describes the development background of the pharmaceutical industry and the development status of the Chinese patent medicine industry from both international and domestic aspects.Secondly,it reads and combs the literature related to cost control,forms a literature review,explains the research content and research and development methods.Thirdly,the definition of the core words "cost" and "cost control" is given,and the relevant theoretical basis is briefly elaborated Thirdly,TH Pharmaceutical Company is introduced to outline the basic situation of the enterprise,analyze the status quo of cost control in its R&D,procurement,production and sales links,supplemented by flow chart,and find that the overall situation of enterprise cost control is extensive,ignoring the importance of cost control,and point out that The problems and internal reasons of cost control in each link.Finally,according to the above problems,corresponding improvement measures and other safeguard measures are put forward,and the full text is summarized and prospects are put forward.The cost control of case enterprises is strengthened,and their cost control system is optimized and perfected,which can provide useful reference for other pharmaceutical enterprises in China in cost control.